Pregnant women with hepatitis c get new hope from 12-Week drug trial
Disease control
Ongoing
This study tests a 12-week course of the drug Sofosbuvir/Velpatasvir in about 100 pregnant women with chronic hepatitis C. The goal is to see if the treatment can cure the virus and whether it affects the timing of delivery. Mothers are followed for 12 weeks after treatment, and …
Phase: PHASE4 • Sponsor: Catherine Anne Chappell • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC